LifeVantage Declares Quarterly Dividend
LifeVantage (Nasdaq: LFVN), a prominent health and wellness company, has announced a quarterly cash dividend of $0.04 per share of common stock. The dividend will be paid on September 17, 2024, to stockholders of record at the close of business on September 9, 2024. LifeVantage specializes in products designed to activate optimal health processes at the cellular level. This dividend declaration demonstrates the company's commitment to returning value to its shareholders and may indicate confidence in its financial stability and future prospects.
LifeVantage (Nasdaq: LFVN), una rinomata azienda nel settore della salute e del benessere, ha annunciato un dividendo in denaro trimestrale di $0,04 per azione di azioni ordinarie. Il dividendo sarà pagato il 17 settembre 2024 agli azionisti registrati alla chiusura delle operazioni del 9 settembre 2024. LifeVantage si specializza in prodotti progettati per attivare i processi di salute ottimale a livello cellulare. Questa dichiarazione di dividendo dimostra l'impegno dell'azienda a restituire valore ai propri azionisti e può indicare fiducia nella sua stabilità finanziaria e nelle prospettive future.
LifeVantage (Nasdaq: LFVN), una empresa destacada en el sector de la salud y el bienestar, ha anunciado un dividendo en efectivo trimestral de $0.04 por acción de acciones ordinarias. El dividendo se pagará el 17 de septiembre de 2024 a los accionistas registrados al cierre de negocios del 9 de septiembre de 2024. LifeVantage se especializa en productos diseñados para activar procesos de salud óptimos a nivel celular. Esta declaración de dividendo demuestra el compromiso de la empresa de devolver valor a sus accionistas y puede indicar confianza en su estabilidad financiera y perspectivas futuras.
LifeVantage (나스닥: LFVN), 저명한 건강 및 웰빙 회사가 보통주 1주당 $0.04의 분기 현금 배당금을 발표했습니다. 이 배당금은 2024년 9월 17일에 지급될 예정이며, 2024년 9월 9일 업무 종료 시점에 주주 명부에 등록된 주주에게 지급됩니다. LifeVantage는 세포 수준에서 최적의 건강 과정을 활성화하기 위해 설계된 제품을 전문으로 합니다. 이 배당금 선언은 회사가 주주에게 가치를 반환하겠다는 의지를 보여주며, 재무 안정성과 미래 전망에 대한 자신감을 나타낼 수 있습니다.
LifeVantage (Nasdaq: LFVN), une entreprise de santé et de bien-être de premier plan, a annoncé un dividende en espèces trimestriel de 0,04 $ par action ordinaire. Le dividende sera versé le 17 septembre 2024 aux actionnaires inscrits à la clôture des affaires le 9 septembre 2024. LifeVantage se spécialise dans les produits conçus pour activer les processus de santé optimaux au niveau cellulaire. Cette déclaration de dividende démontre l'engagement de l'entreprise à restituer de la valeur à ses actionnaires et pourrait indiquer une confiance dans sa stabilité financière et ses perspectives d'avenir.
LifeVantage (Nasdaq: LFVN), ein bedeutendes Unternehmen im Bereich Gesundheit und Wellness, hat eine quartalsweise Barausschüttung von 0,04 USD pro Aktie der Stammaktien angekündigt. Die Ausschüttung wird am 17. September 2024 an die Aktionäre ausgezahlt, die zum Ende des Geschäftstags am 9. September 2024 im Aktienregister stehen. LifeVantage spezialisiert sich auf Produkte, die darauf abzielen, optimale Gesundheitsprozesse auf zellulärer Ebene zu aktivieren. Diese Dividendenankündigung zeigt das Engagement des Unternehmens, seinen Aktionären Wert zurückzugeben, und könnte auf Vertrauen in seine finanzielle Stabilität und zukünftige Perspektiven hinweisen.
- Declared a quarterly dividend of $0.04 per share
- Consistent dividend payments suggest financial stability
- None.
SALT LAKE CITY, Aug. 28, 2024 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that the Company’s Board of Directors has approved a quarterly cash dividend of
About LifeVantage Corporation
LifeVantage Corporation (Nasdaq: LFVN), the activation company, is a pioneer in nutrigenomics, the study of how nutrition and naturally occurring compounds affect human genes to support good health. The Company engages in the identification, research, development, formulation and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and probiotics, weight management, and skin and hair care products. The Company’s line of scientifically-validated dietary supplements includes its flagship Protandim® family of products, LifeVantage® Omega+, ProBio, IC Bright®, Daily Wellness, Rise AM, Reset PM, and D3+ dietary supplements, the TrueScience® line of skin and hair care products and Liquid Collagen. The Company also markets and sells Petandim®, its companion pet supplement formulated to combat oxidative stress in dogs, and Axio®, its nootropic energy drink mixes. LifeVantage was founded in 2003 and is headquartered in Lehi, Utah. For more information, visit www.lifevantage.com.
Cautionary Note Regarding Forward Looking Statements
This document contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Words and expressions reflecting optimism, satisfaction or disappointment with current prospects, as well as words such as "believe," "will," "hopes," "intends," "estimates," "expects," "projects," "plans," "anticipates," "look forward to," "goal," “may be,” and variations thereof, identify forward-looking statements, but their absence does not mean that a statement is not forward-looking. The declaration and/or payment of a dividend during any quarter provides no assurance as to future dividends, and the timing and amount of future dividends, if any, could vary significantly in comparison both to past dividends and to current expectations. Examples of forward-looking statements include, but are not limited to, statements we make regarding executing against and the benefits of our key initiatives, future growth, including geographic and product expansion, the impact of COVID-19 on our business, expected financial performance, and expected dividend payments in future quarters. Such forward-looking statements are not guarantees of performance and the Company's actual results could differ materially from those contained in such statements. These forward-looking statements are based on the Company's current expectations and beliefs concerning future events affecting the Company and involve known and unknown risks and uncertainties that may cause the Company's actual results or outcomes to be materially different from those anticipated and discussed herein. These risks and uncertainties include, among others, further deterioration to the global economic and operating environments as a result of future COVID-19 developments, as well as those discussed in greater detail in the Company's Annual Report on Form 10-K and the Company's Quarterly Report on Form 10-Q under the caption "Risk Factors," and in other documents filed by the Company from time to time with the Securities and Exchange Commission (the “SEC”). The Company cautions investors not to place undue reliance on the forward-looking statements contained in this document. All forward-looking statements are based on information currently available to the Company on the date hereof, and the Company undertakes no obligation to revise or update these forward-looking statements to reflect events or circumstances after the date of this document, except as required by law.
Investor Relations Contact:
Reed Anderson, ICR
(646) 277-1260
reed.anderson@icrinc.com
FAQ
What is the dividend amount for LifeVantage (LFVN) in Q3 2024?
When will LifeVantage (LFVN) pay its Q3 2024 dividend?
What is the record date for LifeVantage's (LFVN) Q3 2024 dividend?
How often does LifeVantage (LFVN) pay dividends?
